*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>1-(3,4-Dihydro-2H-chromen-2-yl)methanamine</strong> is a key intermediate in pharmaceutical synthesis, primarily utilized for constructing chroman-based scaffolds. The standard industrial process involves reductive amination of 3,4-dihydro-2H-chromen-2-one with ammonia or amines under catalytic hydrogenation. Its molecular formula is <strong>C10H13NO</strong> and CAS number is <strong>67569-38-4</strong>.</p>
<h3>Application</h3>
<ul>
<li>Synthetic intermediates for cardiovascular therapeutic agents.</li>
<li>Precursors for developing antihypertensive drugs targeting angiotensin receptors.</li>
<li>R&D materials for novel psychoactive compound libraries.</li>
</ul>
<h3>Precautions</h3>
<p>Requires storage in sealed containers at cool, dry conditions below 25°C to prevent oxidation. Personnel must wear appropriate PPE including nitrile gloves and safety goggles due to potential skin irritation and respiratory sensitivity during handling.</p>